Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.42 |
| ▸ | CSF1R | P07333 | 1/20 | 0.37 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.37 |
| ▸ | WNT3A | P56704 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12844302 | 0.87 | CYP3A4 (0.77) | CYP3A4ALDH1A1SMN1; SMN2PLK1KDM4E | |
| SCHEMBL12000232 | 0.86 | CYP3A4 (0.77) | CYP3A4ALDH1A1SMN1; SMN2PTGS2POLB | |
| SCHEMBL18397104 | 0.85 | ALDH1A1 (0.53) | CYP3A4ALDH1A1SMN1; SMN2PLK1KDM4E | |
| SCHEMBL29859704 | 0.85 | ALDH1A1 (0.53) | CYP3A4ALDH1A1SMN1; SMN2PLK1KDM4E | |
| SCHEMBL2800254 | 0.85 | CYP3A4 (0.53) | CYP3A4ALDH1A1SMN1; SMN2PLK1KDM4E | |
| SCHEMBL12776179 | 0.82 | CYP3A4 (0.50) | CYP3A4ALDH1A1SMN1; SMN2PLK1KDM4E | |
| SCHEMBL5305466 | 0.80 | ALDH1A1 (0.48) | CYP3A4ALDH1A1SMN1; SMN2PLK1KDM4E | |
| SCHEMBL31166209 | 0.80 | ALDH1A1 (0.48) | CYP3A4ALDH1A1SMN1; SMN2PLK1KDM4E | |
| SCHEMBL30542231 | 0.78 | PTGS2 (0.47) | CYP3A4ALDH1A1SMN1; SMN2PTGS2POLB | |
| SCHEMBL26462276 | 0.78 | PTGS2 (0.47) | CYP3A4ALDH1A1SMN1; SMN2PTGS2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110306597-A1 | Nicotinamide Derivatives | CRAWFORTH JAMES MICHAEL (GB) | 2011-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306597-A1 | Nicotinamide Derivatives | NNT, NAMPT, NQO1 | CYP3A4 226/4885ALDH1A1 172/4885SMN1; SMN2 1659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.